MARSHALL WACE, LLP - CALLIDITAS THERAPEUTICS AB ownership

CALLIDITAS THERAPEUTICS AB's ticker is CALT and the CUSIP is 13124Q106. A total of 14 filers reported holding CALLIDITAS THERAPEUTICS AB in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of CALLIDITAS THERAPEUTICS AB
ValueSharesWeighting
Q1 2022$518,000
-74.1%
27,910
-65.4%
0.00%
-75.0%
Q4 2021$1,997,000
+816.1%
80,673
+922.9%
0.00%
+300.0%
Q1 2021$218,0007,8870.00%
Other shareholders
CALLIDITAS THERAPEUTICS AB shareholders Q2 2021
NameSharesValueWeighting ↓
BVF INC/IL 750,000$13,695,0000.37%
IRONWOOD INVESTMENT MANAGEMENT LLC 26,688$487,3230.30%
SPHERA FUNDS MANAGEMENT LTD. 11,863$216,6180.04%
Nalls Sherbakoff Group, LLC 35$6400.00%
DEUTSCHE BANK AG\ 90,550$1,653,4430.00%
Citadel Advisors 2,700$49,3020.00%
Citadel Advisors 5,500$100,4300.00%
Citadel Advisors 4,958$90,5330.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 22,100$403,5460.00%
SIMPLEX TRADING, LLC 536$90.00%
View complete list of CALLIDITAS THERAPEUTICS AB shareholders